Research summary ·
Romiplostim in the management of severe aplastic anemia: a comprehensive clinical review.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This review looked at the drug romiplostim for severe aplastic anemia. In this rare illness, the bone marrow fails to make enough blood cells. The authors searched medical databases up to March 2026. They pulled together trials, records of past patients, and case reports in children. They looked at blood counts, the need for blood transfusions, and harms.
What they found
The review found 19 studies with more than 390 people. Romiplostim seemed to work in both children and adults. Blood counts rose in many people, but this varied a lot between studies. In some people, all blood cell types came back. Higher doses of 10-20 µg/kg/week were linked to better results. Starting the drug early was also linked to better results. This was clearest in people whom eltrombopag had not helped. Long-term use was well tolerated. Rates of serious harm and of harmful changes in marrow cells were low.
What it means for patients
The authors say romiplostim works and is safe in this illness. They see it as a choice when usual treatments fail or cannot be used. They say it could be used as a first or a later treatment. It may bring lasting recovery of all blood cell types. Some people may then no longer need blood transfusions.
Why it is not certain yet
The share of people who got better varied widely between studies. The review mixed trials with records of past patients and case reports. The authors say more work is needed on dose and length of treatment. They also want to learn how it works with other drugs. A review can only be as good as the studies in it.
Source
Romiplostim in the management of severe aplastic anemia: a comprehensive clinical review.
PubMed · PMID 42104146We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Aplastic anaemia publications